Profile change history

What changed for Apraglutide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Apraglutide identity.

8Total events
8Record additions
0Version changes
3Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 8 connected records →

Showing the latest 8 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

ClinicalTrials.gov record NCT04627025

PeptideScanner retained ClinicalTrials.gov record NCT04627025 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-11-27, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
November 27, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04699032

PeptideScanner retained ClinicalTrials.gov record NCT04699032 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
October 26, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04964986

PeptideScanner retained ClinicalTrials.gov record NCT04964986 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-06-18, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
June 18, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05018286

PeptideScanner retained ClinicalTrials.gov record NCT05018286 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-02, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
July 2, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05706623

PeptideScanner retained ClinicalTrials.gov record NCT05706623 at 2026-11-16T01:47:19.543Z. Its registry update date was 2025-07-10, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
July 10, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05995704

PeptideScanner retained ClinicalTrials.gov record NCT05995704 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-24, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
October 24, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06002555

PeptideScanner retained ClinicalTrials.gov record NCT06002555 at 2026-11-16T01:47:19.543Z. Its registry update date was 2024-10-26, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
October 26, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07742735

PeptideScanner retained ClinicalTrials.gov record NCT07742735 at 2026-11-16T01:47:19.543Z. Its registry update date was 2026-08-04, and PeptideScanner's reviewed identity mapping was apraglutide.

PeptideScanner change date
November 16, 2026
Cited source date
August 4, 2026
Evidence lane
Clinical trials